Cover Image
市場調查報告書

Medesis Pharma S.A. - 產品平台分析

Medesis Pharma S.A. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 253811
出版日期 內容資訊 英文 19 Pages
訂單完成後即時交付
價格
Back to Top
Medesis Pharma S.A. - 產品平台分析 Medesis Pharma S.A. - Product Pipeline Review - 2015
出版日期: 2015年06月24日 內容資訊: 英文 19 Pages
簡介

Medesis Pharma S.A. 是開發以對糖尿病治療及神經學而言有效的藥理活性金屬為基礎之治療藥、及RNA (siRNA),微RNA (miRNA)的生物科技企業。

本報告提供Medesis Pharma S.A.的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Medesis Pharma S.A.的基本資料

Medesis Pharma S.A.概要

  • 主要資訊
  • 企業資料

Medesis Pharma S.A.:R&D概要

  • 主要的治療範圍

Medesis Pharma S.A.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Medesis Pharma S.A.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Medesis Pharma S.A.:藥物簡介

  • NP-01
  • NP-03
  • Pep42-TAT Peptide

Medesis Pharma S.A.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Medesis Pharma S.A.:暫停中的計劃

Medesis Pharma S.A.:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07169CDB

Summary

Global Markets Direct's, 'Medesis Pharma S.A. - Product Pipeline Review - 2015', provides an overview of the Medesis Pharma S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Medesis Pharma S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Medesis Pharma S.A. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Medesis Pharma S.A.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Medesis Pharma S.A.'s pipeline products

Reasons to buy

  • Evaluate Medesis Pharma S.A.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Medesis Pharma S.A. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Medesis Pharma S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Medesis Pharma S.A. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medesis Pharma S.A.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Medesis Pharma S.A. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Medesis Pharma S.A. Snapshot
    • Medesis Pharma S.A. Overview
    • Key Information
    • Key Facts
  • Medesis Pharma S.A. - Research and Development Overview
    • Key Therapeutic Areas
  • Medesis Pharma S.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Medesis Pharma S.A. - Pipeline Products Glance
    • Medesis Pharma S.A. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Medesis Pharma S.A. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Medesis Pharma S.A. - Drug Profiles
    • lithium citrate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NP-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NP-42T
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Medesis Pharma S.A. - Pipeline Analysis
  • Medesis Pharma S.A. - Pipeline Products by Route of Administration
  • Medesis Pharma S.A. - Pipeline Products by Molecule Type
  • Medesis Pharma S.A. - Dormant Projects
  • Medesis Pharma S.A. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Medesis Pharma S.A., Key Information
  • Medesis Pharma S.A., Key Facts
  • Medesis Pharma S.A. - Pipeline by Indication, 2015
  • Medesis Pharma S.A. - Pipeline by Stage of Development, 2015
  • Medesis Pharma S.A. - Monotherapy Products in Pipeline, 2015
  • Medesis Pharma S.A. - Phase I, 2015
  • Medesis Pharma S.A. - Preclinical, 2015
  • Medesis Pharma S.A. - Pipeline by Route of Administration, 2015
  • Medesis Pharma S.A. - Pipeline by Molecule Type, 2015
  • Medesis Pharma S.A. - Dormant Developmental Projects,2015

List of Figures

  • Medesis Pharma S.A. - Pipeline by Top 10 Indication, 2015
  • Medesis Pharma S.A. - Pipeline by Stage of Development, 2015
  • Medesis Pharma S.A. - Monotherapy Products in Pipeline, 2015
  • Medesis Pharma S.A. - Pipeline by Top 10 Route of Administration, 2015
  • Medesis Pharma S.A. - Pipeline by Top 10 Molecule Type, 2015
Back to Top